5th Annual World Health Care Congress Hosted by BettrLife: mHealth's Impact on Patient Wellness and the Healthcare Industry
Written by Alyssa Clark
5th Annual World Health Care Congress Hosted by BettrLife: mHealth’s Impact on Patient Wellness and the Healthcare Industry
Coming up this week on Thursday, July 25th is the world renowned and 5th Annual mHealth World Congress, set to be held in Boston, Massachusetts. The Health and Wellness technology company BettrLife will host the event, featuring a panel of esteemed healthcare industry experts who will be discussing a range of topics from mHealth to current industry trends.
Leading the program this week will be Don Schoen, BettrLife CEO, as he discusses the recent impact of medical industry technology and mHealth on patient wellness and user engagement. With the constant evolution of patient needs, resources and opportunities, the medical field is calling to action an established panel to shed some light on the current issues darkening the lives of many of today’s healthcare patients. Simply from recent studies showing the impact of mHealth on the industry alone call for a redirected focus to what we can do as industry professionals to better deliver to our customers.
A survey by Research2guidance recently revealed that the mHealth market will reach $26 billion by 2017; with this kind of budgeting for mHealth markets, the sky is the limit for healthcare leaders to better accommodate and serve their patients as resources become more and more available through technology and mobile health services.
Innovation, using technology and adapting to change are all core traits to be discussed this year, and there stands to be no one better than BettrLife to host this year’s event, seeing as how they embody and pride themselves on every principle that the panel is set to discuss this year. Similar to the meeting of industry professionals and the world health congress, BettrLife brings patients and their health professionals through web portals and personalized engagement. BettrLife will not only be hosting the event, but will be actively involved in the conference as an exhibitor as well.
“BettrLife is part a transformation from reactive, to proactive management of personal health and wellness using mobile technology,” said Schoen. “We are excited to help facilitate a discussion among stakeholders in this emerging space.”
The panel for the 5th Annual World Health Congress will consist of: Travis Good (Co-founder of Catalyze.io), Rajni Aneja (Strategic Executive, Clinical Transformation Leader, Humana), Nebeyou Abebe (Associate Director, Louisiana Public Health Institute) and Lynne A. Dunbrack (Program Director, IDC health insights). Hosted by Don Schoen as stated before, this group of respected industry professionals will provide insight onto the future of the healthcare field, while discussing the pros and cons of technological industry developments.
About the Author
Alyssa Clark is the Editor of Healthcare Global
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”